Partners in Discovery
Partners in Discovery
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.
No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.
Harnessing the power of
science for our patients
Our doctors and researchers are turning today's
scientific discoveries into tomorrow's treatments.
Learn more about our research programs and initiatives.
Proven Track Record
A leader in research, innovation and treatment. We are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.
Patients, Partners, Progress
Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.
Read their stories from Momentum magazine.
Cancer Center News
Latest news about our research, patient care programs, outreach and educational events.
COVID-19 and Cancer Consortium study highlights racial disparities, increased mortality for patients facing dual diagnoses
The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection.
EGFR Resisters/LUNGevity fund lung cancer research
Christine Lovly, MD, PhD, associate professor of Medicine in the Division of Hematology and Oncology and Ingram Professor of Cancer Research, is one of two inaugural recipients of the EGFR Resisters/LUNGevity Lung Cancer Research Award.
Vanderbilt research played key role in new lung screen guidelines
The U.S. Preventive Services Task Force (USPSTF) has formally recommended two changes that will nearly double the number of people eligible for lung cancer screening.
Vanderbilt Health now offering endoscopy at One Hundred Oaks
The new Endoscopy Lab at One Hundred Oaks has expanded Vanderbilt Health’s options for endoscopic procedures including colonoscopies to screen for colorectal cancer.
Process ensures follow-up of incidental radiology findings
A team at Vanderbilt University Medical Center recently established a better process for ensuring patients receive follow-up diagnostic care, an initiative that is already receiving national recognition.
Gene network for leukemia factor
Stengel, Hiebert, and colleagues have devised a chemical genetic approach that speeds transcription factor analysis from days to minutes.